<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">JBRA Assist Reprod</journal-id><journal-id journal-id-type="iso-abbrev">JBRA Assist Reprod</journal-id><journal-id journal-id-type="publisher-id">jbra</journal-id><journal-title-group><journal-title>JBRA Assisted Reproduction</journal-title></journal-title-group><issn pub-type="ppub">1517-5693</issn><issn pub-type="epub">1518-0557</issn><publisher><publisher-name>Brazilian Society of Assisted Reproduction</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5714606</article-id><article-id pub-id-type="doi">10.5935/1518-0557.20170057</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>There is no association between the presence of anti-thyroid
antibodies and increased reproductive loss in pregnant women after ART: a
systematic review and meta-analysis</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Leiva</surname><given-names>Paz</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Schwarze</surname><given-names>Juan Enrique</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="c1"/></contrib><contrib contrib-type="author"><name><surname>Vasquez</surname><given-names>Pamela</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Ortega</surname><given-names>Carolina</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Villa</surname><given-names>Sonia</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Crosby</surname><given-names>Javier</given-names></name><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Balmaceda</surname><given-names>Jos&#x000e9;</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Pommer</surname><given-names>Ricardo</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib></contrib-group><aff id="aff1">
<label>1</label>Obstetrics and Gynecology Department at Universidad de Santiago,
Chile</aff><aff id="aff2">
<label>2</label>Reproductive Medicine Unit at Clinica Monteblanco</aff><aff id="aff3">
<label>3</label>Epidemiology Department, Universidad de los Andes, Chile</aff><aff id="aff4">
<label>4</label>Reproductive Medicine Unit at Clinica Las Condes</aff><author-notes><corresp id="c1"><bold>Corresponding author:</bold> Juan Enrique Schwarze,
Reproductive Medicine Unit, Clinica Monteblanco, Santiago, Chile. E-mail:
<email>jeschwarze@gmail.com</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>Oct-Dec</season><year>2017</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Oct-Dec</season><year>2017</year></pub-date><volume>21</volume><issue>4</issue><fpage>361</fpage><lpage>365</lpage><history><date date-type="received"><day>02</day><month>4</month><year>2017</year></date><date date-type="accepted"><day>07</day><month>8</month><year>2017</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><p>Women submitted to ART treatments represent a select subgroup of individuals.
Several studies have described the relationship between TAI and pregnancy
outcomes as a result of ART, with contradictory results. The purpose of this
systematic review was to determine the association between TAI and the risk of
miscarriage in pregnancies resulting from ART. MEDLINE via PubMed, LILACS and
Embase were searched for studies published in peer-reviewed journals from 1999
to 2017. The studies were summarized using the fixed effects model and the
Peto's method to calculate RR in order to flesh out the association between TAI
and spontaneous abortion. Only four papers were included in this systematic
review and meta-analysis. Thirty-one miscarriages were observed in 210 clinical
pregnancies of women with antithyroid antibodies; and 158 miscarriages were seen
in 1,371 pregnancies without antithyroid antibodies. The meta-analysis failed to
find an association between TAI and higher risk of reproductive loss, RR=0.94
95% confidence interval: 0.71-1.24; <italic>p</italic>=0.879. In conclusion, the
presence of antithyroid antibodies was not associated with increased
reproductive loss in patients submitted to ART treatments. It is our opinion
that the presence of antithyroid antibodies should be considered as a secondary
biomarker of autoimmune disease, rather than an actual cause of miscarriage in
patients undergoing ART. Due to the small amount of evidence on the matter, the
determination of TAI before the initiation of ART should be limited to research
contexts.</p></abstract><kwd-group><kwd>ART</kwd><kwd>anitbodies</kwd><kwd>thyroid</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>INTRODUCTION</title><p>The percentage of women in the general population with thyroid autoimmunity (TAI),
whether by thyroglobulin autoantibodies (anti-Tg) or anti-thyroid peroxidase
antibodies (TPOAb), may be as high as 20% (<xref rid="r4" ref-type="bibr">Davies,
2016</xref>; <xref rid="r8" ref-type="bibr">&#x00141;ukaszuk <italic>et al.</italic>,
2015</xref>). In 1930, <xref rid="r15" ref-type="bibr">Stagnaro-Green <italic>et
al.</italic> (1990)</xref> described the association between TAI and risk of
spontaneous abortion. Since then, increased risk of fetal loss, perinatal mortality,
and large for gestational age (LGA) newborns have been reported for euthyroid women
with elevated concentrations of TPOAb (<xref rid="r2" ref-type="bibr">Bussen &#x00026;
Steck, 1995</xref>; <xref rid="r14" ref-type="bibr">Prummel &#x00026; Wiersinga,
2004</xref>; <xref rid="r9" ref-type="bibr">M&#x000e4;nnist&#x000f6; <italic>et
al</italic>. 2009</xref>). Other studies suggested that the presence of TAI
in euthyroid women was associated with a 2-3 fold higher risk of miscarriage (<xref rid="r3" ref-type="bibr">Chen &#x00026; Hu, 2011</xref>; <xref rid="r17" ref-type="bibr">Thangaratinam <italic>et al</italic>., 2011</xref>). The causality and
pathophysiology of this association, or the adequate course of treatment, have not
been completely elucidated.</p><p>Women submitted to assisted reproductive technology (ART) treatments represent a
select subgroup of individuals. Several studies have described the relationship
between TAI and pregnancy outcomes as a result of ART, with contradictory results
(<xref rid="r1" ref-type="bibr">Abalovich <italic>et al.</italic>, 2007</xref>;
<xref rid="r16" ref-type="bibr">Stagnaro-Green &#x00026; Glinoer, 2004</xref>). The
purpose of this systematic review was to determine the association between TAI and
the risk of miscarriage in pregnancies resulting from ART.</p></sec><sec sec-type="materials|methods"><title>MATERIALS AND METHODS</title><sec><title>Electronic search</title><p>MEDLINE via PubMed, LILACS and Embase were searched for papers written in English
and Spanish published in peer-reviewed journals from 1999 to 2017. Search terms
"antithyroid antibodies" "assisted reproductive techniques", and the combined
MeSH terms "reproductive techniques, assisted OR fertilization <italic>in
vitro</italic> OR sperm injections, intracytoplasmic" AND "thyroid gland"
AND "autoantibodies" were used. Additional studies were found in the references
of the retrieved papers.</p></sec><sec><title>Study selection</title><p>Studies looking into ART in women with ages ranging from 22 to 45 years were
eligible for inclusion in the review. Secondary studies, studies without
comparable groups, and studies performing Preimplantation Genetic Diagnosis were
excluded.</p><p>The papers were selected based on their titles and abstracts according to the
inclusion criteria (<xref ref-type="fig" rid="f1">Figure 1</xref>).</p><p>
<fig id="f1" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Systematic review flowchart.</p></caption><graphic xlink:href="jbra-21-04-0361-g01"/></fig>
</p></sec><sec><title>Selected outcomes</title><p>Papers comparing the pregnancy outcomes of individuals with and without TAI
offered ART treatments were included, whereas studies not reporting pregnancy
outcomes were not included (e.g. birth or miscarriage).</p></sec><sec><title>Data extraction</title><p>Two independent authors reviewed the titles and abstracts (PL and JES), and when
applicable the full text was retrieved for further analysis. The independent
authors assessed the papers for compliance with the inclusion criteria.
Disagreements were resolved with the aid of a third author (CO). Data was
extracted by one of the authors (PL) in a specially designed form that included
references, study type, methods, results, and conclusions.</p></sec><sec><title>Methods of synthesis</title><p>The studies were summarized using the fixed effects model and Peto&#x000b4;s method to
calculate relative risk (RR) and 95% confidence intervals to further elicit the
association between TAI and spontaneous abortion in women offered ART.
Statistical analysis was performed on STATA 11.0 (STATA Corp, EEUU). The results
were displayed in a forest plot (<xref ref-type="fig" rid="f2">Figure
2</xref>).</p><p>
<fig id="f2" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Forest plot: RR of miscarriage in TAI (+) patients undergoing
ART.</p></caption><graphic xlink:href="jbra-21-04-0361-g02"/></fig>
</p><p>Heterogeneity between studies was assessed with Higgins' I<sup>2</sup> and
Cochran's Q test. Heterogeneity was considered to be significant when
<italic>p</italic>&#x0003c;0.01 and I<sup>2</sup>&#x0003e;30%.</p></sec></sec><sec sec-type="results"><title>RESULTS</title><p>The initial search retrieved 31 studies. No duplicates were found. After screening
for titles and abstracts, 24 studies were excluded for not meeting the inclusion
criteria. Seven remained for full text revisions, but three included ongoing
pregnancies and were therefore excluded. Four papers met the inclusion criteria and
were included in the systematic review and meta-analysis (<xref ref-type="fig" rid="f2">Figure 2</xref>).</p><p>The four studies included were published between 1999 and 2015 and covered a total of
2,664 women offered ART. The main findings are summarized in <xref ref-type="table" rid="t1">Table 1</xref>. Two of the studies were carried out in Europe, one in
Asia, and one in the United States. All were retrospective cohort studies.</p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Summary of included studies.</p></caption><table frame="box" rules="all"><colgroup span="1"><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1"><break/>Author, year. Country</th><th align="left" rowspan="1" colspan="1">Methods</th><th align="left" rowspan="1" colspan="1">TAI (+)</th><th align="left" rowspan="1" colspan="1">TAI (-)</th><th align="left" rowspan="1" colspan="1">Conclusions</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Lukaszuk <italic>et al.</italic>,
2015. China</bold></td><td align="left" valign="top" rowspan="1" colspan="1">Retrospective Cohort study of euthyroid
women, age 34-35 years, submitted to IVF/ICSI between April 2010 and
April 2012. <break/> Population was divided in 2 groups: patients
with TPOAb+ (n=114) and TPOAb- (n=495) <break/> Measurement of TPOAb
by&#x000a0; &#x000a0;ECLIA. Reference value: 0-34 IU/ml </td><td align="left" valign="top" rowspan="1" colspan="1"><bold>Clinical Pregnancy:</bold><break/>
n=50 <break/><bold>Miscarriage: </bold><break/> n=3</td><td align="left" valign="top" rowspan="1" colspan="1"><bold>Clinical Pregnancy: </bold><break/>
n=235 <break/><bold>Miscarriage: </bold><break/> n=29</td><td align="left" valign="top" rowspan="1" colspan="1">IVF patients undergoing ICSI with TPOAb+
vs TPOAb- did not present statistically significant differences in
fertilization, implantation, pregnancy, and live newborn
rates.<break/> The presence of TPOAb did not increase the risk of
miscarriage &#x000a0;(6% vs. 12.4%, <italic>p</italic>=0.29)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Zhong <italic>et al.</italic>, 2012.
Poland</bold></td><td align="left" valign="top" rowspan="1" colspan="1">Retrospective cohort study of patients
(mean age=32 years) submitted to IVF/ICSI&#x000a0;between August 2009 and
August 2010.<break/> Population was divided in two groups: patients
with TAI [TPOAb+ and/or &#x000a0;anti-Tg+] (n=90) and without &#x000a0;TAI
(n=676)<break/> Measurement of TAI by CMIA:<break/> -TPOAb+
&#x02265;561UI/ml <break/> -anti-Tg+] &#x02265;4.11UI/ml</td><td align="left" valign="top" rowspan="1" colspan="1"><bold>Clinical Pregnancy:</bold><break/>
n=52 <break/><bold>Miscarriage</bold>: <break/> n=14</td><td align="left" valign="top" rowspan="1" colspan="1"><bold>Clinical Pregnancy: </bold><break/>
n=458 <break/><bold>Miscarriage</bold>: <break/> n=54</td><td align="left" valign="top" rowspan="1" colspan="1">Fertilization implantation and pregnancy
rates after IVF-ET were significantly lower&#x000a0; (64.3% vs. 74.6%,
<italic>p</italic>&#x0003c;0.001; 17.8% vs. 27.1%,
<italic>p</italic>&#x0003c;0.001; and 33.3% vs. 46.7%,
<italic>p</italic>=0.002, respectively), whereas miscarriage rates
were significantly higher (26.9% vs. 11.8%) in patients with TAI
versus controls (without TAI).</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Negro <italic>et al</italic>., 2007
Italy</bold></td><td align="left" valign="top" rowspan="1" colspan="1">Retrospective Cohort study of euthyroid
women aged 20-35 years, carried out between January 2000 and January
&#x000a0;2005. <break/> A total of 416 patients were selected; 42 had TPOAb+
and &#x000a0;374 TPOAb-.<break/> Measurement method of TPOAb by
&#x000a0;RIA:<break/> -TPOAb+ &#x02265;100 Ku/l</td><td align="left" valign="top" rowspan="1" colspan="1"><bold>Clinical Pregnancy: </bold><break/>
n=21 <break/><bold>Miscarriage</bold>: <break/> n=5</td><td align="left" valign="top" rowspan="1" colspan="1"><bold>Clinical Pregnancy: </bold><break/>
n=234 <break/><bold>Miscarriage</bold>:<break/> n=27</td><td align="left" valign="top" rowspan="1" colspan="1">In euthyroid patients, pregnancy and
delivery rates were not affected by the presence of TPOAb.<break/>
In patients with TPOAb+, the subgroup of patients that did not
achieve pregnancy had miscarriages had higher TSH levels, but within
the normal range &#x000a0;(2.8mUI/ml) vs. patients that delivered (TSH 1.06
mUI/ml, <italic>p</italic>=0.032)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Kutteh <italic>et al.</italic>, 1999
USA</bold></td><td align="left" valign="top" rowspan="1" colspan="1">Retrospective cohort study of women aged
35&#x000b1;4 years offered IVF in 3 centers in the USA between April
1996 and April 1997. <break/> From a total of 873 patients with ART,
143 women had TAI [TPOAb+ and/or &#x000a0;anti-Tg+].<break/> Results were
compared to a control group of 200 non-pregnant women of
childbearing age with no record of reproductive problems <break/>
Measurement of AIT with ELISA:<break/> -TPOAb+ &#x02265;65
UI/ml.<break/> -anti-Tg+ &#x02265;120 UI/ml.</td><td align="left" valign="top" rowspan="1" colspan="1"><bold>Clinical Pregnancy</bold><break/>
n=87 <break/><bold>Miscarriage</bold>: <break/> n=9</td><td align="left" valign="top" rowspan="1" colspan="1"><bold>Clinical Pregnancy</bold>: <break/>
n=444 <break/><bold>Miscarriage</bold>: <break/> n=48</td><td align="left" valign="top" rowspan="1" colspan="1">The presence of TAI was similar between
patients offered ART and controls (16.4% vs. 14.5 %, OR:
1.16)<break/> No statistically significant differences were found in
delivery (54.5% vs. 54.2%, <italic>p</italic>=1.00), biochemical
miscarriage (3.5% vs. 4.7%, <italic>p</italic>=0.66), clinical
miscarriage (6.3% vs. 6.6%, <italic>p</italic>=1.00), and pregnancy
failure (35.7% vs. 34.5%, <italic>p</italic>=0.85) rates between
patients with and without TAI. </td></tr></tbody></table></table-wrap><p>The groups were comparable for age in the selected papers. Only two studies mentioned
the nutritional status of the patients with a mean body mass index of
22&#x000b1;4Kg/m<sup>2</sup> (<xref rid="r8" ref-type="bibr">&#x00141;ukaszuk <italic>et
al</italic>., 2015</xref>; <xref rid="r20" ref-type="bibr">Zhong <italic>et
al</italic>., 2012</xref>); two included only euthyroid women and two did
not consider that condition, although they excluded individuals with other
autoimmune diseases.</p><p>The methods used to determine the presence of TAI differed, as did their titrations:
electrochemiluminescence immunoassay (<xref rid="r8" ref-type="bibr">&#x00141;ukaszuk
<italic>et al.</italic>, 2015</xref>), chemiluminescent microparticle
immunoassay (<xref rid="r20" ref-type="bibr">Zhong <italic>et al</italic>.,
2012</xref>), radioimmunoassay (<xref rid="r12" ref-type="bibr">Negro <italic>et
al</italic>., 2007</xref>), and enzyme-linked immunosorbent assay (<xref rid="r7" ref-type="bibr">Kutteh <italic>et al</italic>., 1999</xref>) (<xref ref-type="table" rid="t1">Table 1</xref>). In two studies the anti-Tg and
anti-thyroid peroxidase antibodies levels were measured (<xref rid="r8" ref-type="bibr">&#x00141;ukaszuk <italic>et al</italic>., 2015</xref>; <xref rid="r12" ref-type="bibr">Negro <italic>et al.,</italic> 2007</xref>), while the other two only
the level of anti-thyroid peroxidase antibodies was measured (<xref rid="r7" ref-type="bibr">Kutteh <italic>et al.</italic>, 1999</xref>; <xref rid="r20" ref-type="bibr">Zhong <italic>et al.,</italic> 2012</xref>).</p><p>Thirty-one miscarriages were observed in 210 clinical pregnancies of women with
antithyroid antibodies; and 158 miscarriages were seen in 1,371 pregnancies without
antithyroid antibodies. The meta-analysis failed to find an association between TAI
and higher risk of reproductive loss, RR=0.94 95% confidence interval: 0.71-1.24;
<italic>p</italic>=0.879 (<xref ref-type="fig" rid="f2">Figure 2</xref>).</p><p>The heterogeneity between studies was not significant (<italic>p</italic>=0.879,
I<sup>2</sup>=0.00%).</p></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>The purpose of this review was to determine whether pregnant individuals with TAI
offered ART were at higher risk of having a miscarriage. After summarizing four
studies including a total of 1,581 pregnancies after ART, no association was found
between TAI and miscarriage. Most of the studies included in this meta-analysis
showed no statistically significant differences in fertility rate, number of embryos
available, implantation rate or clinical pregnancy rates between the groups. These
findings were consistent with the results reported by <xref rid="r6" ref-type="bibr">Karacan <italic>et al</italic>. (2013)</xref>, in which implantation rates,
spontaneous abortion rates, and pregnancy rates did not differ significantly between
the groups with TAI and without TAI.</p><p>The strength of this study resided in the large number of analyzed patients, a total
of 2,664 individuals given ART treatments. A weakness of the study was the fact that
levels of thyroglobulin autoantibodies (anti-Tg) were not measured in every included
study, which have been reported to be around 5% in patients suffering from
infertility (<xref rid="r18" ref-type="bibr">Unuane <italic>et al.,</italic>
2013</xref>). Another limitation was that only two studies included euthyroid
patients; the other two did not consider this trait in their inclusion criteria, but
had presence of other autoimmune diseases as a criterion for exclusion.
Levothyroxine was not prescribed to every patient included. Since TSH levels and
prescription of levothyroxine seem to be relevant for IVF outcomes, <xref rid="r13" ref-type="bibr">Poppe <italic>et al</italic>. (2004)</xref> looked
into the thyroid function of females submitted to IVF procedures and the possible
associations with reproductive outcomes, and reported a modified pattern in thyroid
function during the first period of pregnancy after comparing the groups with and
without TAI.</p><p>Most of the patients did not receive levothyroxine during pregnancy. The
meta-analysis performed by <xref rid="r19" ref-type="bibr">Velkeniers <italic>et
al</italic>. (2013)</xref> and the study by <xref rid="r11" ref-type="bibr">Negro <italic>et al</italic>. (2005)</xref> found that thyroxine
supplementation for women with subclinical hypothyroidism and/or thyroid
autoimmunity might improve clinical pregnancy outcomes in patients offered ART,
therefore such supplementation did not interfere with the outcomes described in our
study.</p><p>The discrepancies between the results found in this study and in the papers written
by <xref rid="r20" ref-type="bibr">Zhong <italic>et al</italic>. (2012)</xref> and
<xref rid="r5" ref-type="bibr">Glinoer <italic>et al</italic>. (1991)</xref> may
be explained by the mechanism of action of antithyroid antibodies; although this
mechanism has not been completely described, it has been speculated that the
anti-thyroid peroxidase antibodies can bind to the egg surface and/or embryo and
interfere with fertilization and embryo development (<xref rid="r10" ref-type="bibr">Monteleone <italic>et al.,</italic> 2011</xref>; <xref rid="r20" ref-type="bibr">Zhong <italic>et al.,</italic> 2012</xref>). Our results, although
contradictory at a first glance, seem to confirm this hypothesis: While TPOAb bound
to the egg surface might prevent sperm cells from entering the egg during natural
fertilization or IVF, it should not affect fertilization through intracytoplasmic
sperm injection (ICSI), the method used in all patients in the included studies.</p><p>In conclusion, the presence of antithyroid antibodies was not associated with
increased reproductive loss in patients submitted to ART treatments. It is our
opinion that the presence of antithyroid antibodies should be considered as a
secondary biomarker of autoimmune disease, rather than an actual cause of
miscarriage in patients undergoing ART. Due to the small amount of evidence on the
matter, the determination of TAI before the initiation of ART should be limited to
research contexts.</p></sec></body><back><ref-list><title>REFERENCES</title><ref id="r1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abalovich</surname><given-names>M</given-names></name><name><surname>Amino</surname><given-names>N</given-names></name><name><surname>Barbour</surname><given-names>LA</given-names></name><name><surname>Cobin</surname><given-names>RH</given-names></name><name><surname>De Groot</surname><given-names>LJ</given-names></name><name><surname>Glinoer</surname><given-names>D</given-names></name><name><surname>Mandel</surname><given-names>SJ</given-names></name><name><surname>Stagnaro-Green</surname><given-names>A</given-names></name></person-group><article-title>Management of thyroid dysfunction during pregnancy and
postpartum: an Endocrine Society Clinical Practice Guideline</article-title><source>J Clin Endocrinol Metab</source><year>2007</year><volume>92</volume><fpage>S147</fpage><lpage>S147</lpage><pub-id pub-id-type="doi">10.1210/jc.2007-0141</pub-id><?supplied-pmid 17948378?><pub-id pub-id-type="pmid">17948378</pub-id></element-citation></ref><ref id="r2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bussen</surname><given-names>S</given-names></name><name><surname>Steck</surname><given-names>T</given-names></name></person-group><article-title>Thyroid autoantibodies in euthyroid non-pregnant women with
recurrent spontaneous abortions</article-title><source>Hum Reprod</source><year>1995</year><volume>10</volume><fpage>2938</fpage><lpage>2940</lpage><pub-id pub-id-type="doi">10.1093/oxfordjournals.humrep.a135823</pub-id><?supplied-pmid 8747048?><pub-id pub-id-type="pmid">8747048</pub-id></element-citation></ref><ref id="r3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Hu</surname><given-names>R</given-names></name></person-group><article-title>Thyroid autoimmunity and miscarriage: a
meta-analysis</article-title><source>Clin Endocrinol (Oxf).</source><year>2011</year><volume>74</volume><fpage>513</fpage><lpage>519</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2265.2010.03974.x</pub-id><?supplied-pmid 21198746?><pub-id pub-id-type="pmid">21198746</pub-id></element-citation></ref><ref id="r4"><element-citation publication-type="webpage"><person-group person-group-type="author"><name><surname>Davies</surname><given-names>T</given-names></name></person-group><chapter-title>Pathogenesis of Hashimoto's thyroiditis (chronic autoimmune
thyroiditis)</chapter-title><person-group person-group-type="editor"><collab>UpToDate</collab><name><surname>Post</surname><given-names>TW</given-names></name></person-group><source>UpToDate, Waltham, MA</source><comment>Available at: <ext-link ext-link-type="uri" xlink:href="https://www.uptodate.com/contents/pathogenesis-of-hashimotos-thyroiditis-chronic-autoimmune-thyroiditis">https://www.uptodate.com/contents/pathogenesis-of-hashimotos-thyroiditis-chronic-autoimmune-thyroiditis</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2016-12-16">16/12/2016</date-in-citation></element-citation></ref><ref id="r5"><element-citation publication-type="journal"><person-group person-group-type="editor"><name><surname>Glinoer</surname><given-names>D</given-names></name><name><surname>Soto</surname><given-names>MF</given-names></name><name><surname>Bourdoux</surname><given-names>P</given-names></name><name><surname>Lejeune</surname><given-names>B</given-names></name><name><surname>Delange</surname><given-names>F</given-names></name><name><surname>Lemone</surname><given-names>M</given-names></name><name><surname>Kinthaert</surname><given-names>J</given-names></name><name><surname>Robijn</surname><given-names>C</given-names></name><name><surname>Grun</surname><given-names>JP</given-names></name><name><surname>de Nayer</surname><given-names>P</given-names></name></person-group><article-title>Pregnancy in patients with mild thyroid abnormalities: maternal
and neonatal repercussions</article-title><source>J Clin Endocrinol Metab.</source><year>1991</year><volume>73</volume><fpage>421</fpage><lpage>427</lpage><pub-id pub-id-type="doi">10.1210/jcem-73-2-421</pub-id><?supplied-pmid 1906897?><pub-id pub-id-type="pmid">1906897</pub-id></element-citation></ref><ref id="r6"><element-citation publication-type="journal"><person-group person-group-type="editor"><name><surname>Karacan</surname><given-names>M</given-names></name><name><surname>Alwaeely</surname><given-names>F</given-names></name><name><surname>Cebi</surname><given-names>Z</given-names></name><name><surname>Berberoglugil</surname><given-names>M</given-names></name><name><surname>Batukan</surname><given-names>M</given-names></name><name><surname>Ulug</surname><given-names>M</given-names></name><name><surname>Arvas</surname><given-names>A</given-names></name><name><surname>Caml&#x00131;bel</surname><given-names>T</given-names></name></person-group><article-title>Effect of antithyroid antibodies on ICSI outcome in
antiphospholipid antibody-negative euthyroid women</article-title><source>Reprod Biomed Online</source><year>2013</year><volume>27</volume><fpage>376</fpage><lpage>380</lpage><pub-id pub-id-type="doi">10.1016/j.rbmo.2013.07.002</pub-id><?supplied-pmid 23953066?><pub-id pub-id-type="pmid">23953066</pub-id></element-citation></ref><ref id="r7"><element-citation publication-type="journal"><person-group person-group-type="editor"><name><surname>Kutteh</surname><given-names>WH</given-names></name><name><surname>Schoolcraft</surname><given-names>WB</given-names></name><name><surname>Scott</surname><given-names>RT</given-names><suffix>Jr</suffix></name></person-group><article-title>Antithyroid antibodies do not affect pregnancy outcome in women
undergoing assisted reproduction</article-title><source>Hum Reprod</source><year>1999</year><volume>14</volume><fpage>2886</fpage><lpage>2890</lpage><pub-id pub-id-type="doi">10.1093/humrep/14.11.2886</pub-id><?supplied-pmid 10548642?><pub-id pub-id-type="pmid">10548642</pub-id></element-citation></ref><ref id="r8"><element-citation publication-type="journal"><person-group person-group-type="editor"><name><surname>&#x00141;ukaszuk</surname><given-names>K</given-names></name><name><surname>Kunicki</surname><given-names>M</given-names></name><name><surname>Kulwikowska</surname><given-names>P</given-names></name><name><surname>Liss</surname><given-names>J</given-names></name><name><surname>Pastuszek</surname><given-names>E</given-names></name><name><surname>Jaszczo&#x00142;t</surname><given-names>M</given-names></name><name><surname>M&#x00119;czekalski</surname><given-names>B</given-names></name><name><surname>Skowro&#x00144;ski</surname><given-names>K</given-names></name></person-group><article-title>The impact of the presence of antithyroid antibodies on pregnancy
outcome following intracytoplasmatic sperm injection-ICSI and embryo
transfer in women with normal thyreotropine levels</article-title><source>J Endocrinol Invest</source><year>2015</year><volume>38</volume><fpage>1335</fpage><lpage>1343</lpage><pub-id pub-id-type="doi">10.1007/s40618-015-0377-5</pub-id><?supplied-pmid 26280321?><pub-id pub-id-type="pmid">26280321</pub-id></element-citation></ref><ref id="r9"><element-citation publication-type="journal"><person-group person-group-type="editor"><name><surname>M&#x000e4;nnist&#x000f6;</surname><given-names>T</given-names></name><name><surname>V&#x000e4;&#x000e4;r&#x000e4;sm&#x000e4;ki</surname><given-names>M</given-names></name><name><surname>Pouta</surname><given-names>A</given-names></name><name><surname>Hartikainen</surname><given-names>AL</given-names></name><name><surname>Ruokonen</surname><given-names>A</given-names></name><name><surname>Surcel</surname><given-names>HM</given-names></name><name><surname>Bloigu</surname><given-names>A</given-names></name><name><surname>J&#x000e4;rvelin</surname><given-names>MR</given-names></name><name><surname>Suvanto-Luukkonen</surname><given-names>E</given-names></name></person-group><article-title>Perinatal outcome of children born to mothers with thyroid
dysfunction or antibodies: a prospective population-based cohort
study</article-title><source>J Clin Endocrinol Metab</source><year>2009</year><volume>94</volume><fpage>772</fpage><lpage>779</lpage><pub-id pub-id-type="doi">10.1210/jc.2008-1520</pub-id><?supplied-pmid 19106271?><pub-id pub-id-type="pmid">19106271</pub-id></element-citation></ref><ref id="r10"><element-citation publication-type="journal"><person-group person-group-type="editor"><name><surname>Monteleone</surname><given-names>P</given-names></name><name><surname>Parrini</surname><given-names>D</given-names></name><name><surname>Faviana</surname><given-names>P</given-names></name><name><surname>Carletti</surname><given-names>E</given-names></name><name><surname>Casarosa</surname><given-names>E</given-names></name><name><surname>Uccelli</surname><given-names>A</given-names></name><name><surname>Cela</surname><given-names>V</given-names></name><name><surname>Genazzani</surname><given-names>AR</given-names></name><name><surname>Artini</surname><given-names>PG</given-names></name></person-group><article-title>Female infertility related to thyroid autoimmunity: the ovarian
follicle hypothesis</article-title><source>Am J Reprod Immunol</source><year>2011</year><volume>66</volume><fpage>108</fpage><lpage>114</lpage><pub-id pub-id-type="doi">10.1111/j.1600-0897.2010.00961.x</pub-id><?supplied-pmid 21241400?><pub-id pub-id-type="pmid">21241400</pub-id></element-citation></ref><ref id="r11"><element-citation publication-type="journal"><person-group person-group-type="editor"><name><surname>Negro</surname><given-names>R</given-names></name><name><surname>Mangieri</surname><given-names>T</given-names></name><name><surname>Coppola</surname><given-names>L</given-names></name><name><surname>Presicce</surname><given-names>G</given-names></name><name><surname>Casavola</surname><given-names>EC</given-names></name><name><surname>Gismondi</surname><given-names>R</given-names></name><name><surname>Locorotondo</surname><given-names>G</given-names></name><name><surname>Caroli</surname><given-names>P</given-names></name><name><surname>Pezzarossa</surname><given-names>A</given-names></name><name><surname>Dazzi</surname><given-names>D</given-names></name><name><surname>Hassan</surname><given-names>H</given-names></name></person-group><article-title>Levothyroxine treatment in thyroid peroxidase antibody-positive
women undergoing assisted reproduction technologies: a prospective
study</article-title><source>Hum Reprod</source><year>2005</year><volume>20</volume><fpage>1529</fpage><lpage>1533</lpage><pub-id pub-id-type="doi">10.1093/humrep/deh843</pub-id><?supplied-pmid 15878930?><pub-id pub-id-type="pmid">15878930</pub-id></element-citation></ref><ref id="r12"><element-citation publication-type="journal"><person-group person-group-type="editor"><name><surname>Negro</surname><given-names>R</given-names></name><name><surname>Formoso</surname><given-names>G</given-names></name><name><surname>Coppola</surname><given-names>L</given-names></name><name><surname>Presicce</surname><given-names>G</given-names></name><name><surname>Mangieri</surname><given-names>T</given-names></name><name><surname>Pezzarossa</surname><given-names>A</given-names></name><name><surname>Dazzi</surname><given-names>D</given-names></name></person-group><article-title>Euthyroid women with autoimmune disease undergoing assisted
reproduction technologies: the role of autoimmunity and thyroid
function</article-title><source>J Endocrinol Invest</source><year>2007</year><volume>30</volume><fpage>3</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1007/BF03347388</pub-id><?supplied-pmid 17318015?><pub-id pub-id-type="pmid">17318015</pub-id></element-citation></ref><ref id="r13"><element-citation publication-type="journal"><person-group person-group-type="editor"><name><surname>Poppe</surname><given-names>K</given-names></name><name><surname>Glinoer</surname><given-names>D</given-names></name><name><surname>Tournaye</surname><given-names>H</given-names></name><name><surname>Schiettecatte</surname><given-names>J</given-names></name><name><surname>Devroey</surname><given-names>P</given-names></name><name><surname>van Steirteghem</surname><given-names>A</given-names></name><name><surname>Haentjens</surname><given-names>P</given-names></name><name><surname>Velkeniers</surname><given-names>B</given-names></name></person-group><article-title>Impact of ovarian hyperstimulation on thyroid function in women
with and without thyroid autoimmunity</article-title><source>J Clin Endocrinol Metab</source><year>2004</year><volume>89</volume><fpage>3808</fpage><lpage>3812</lpage><pub-id pub-id-type="doi">10.1210/jc.2004-0105</pub-id><?supplied-pmid 15292309?><pub-id pub-id-type="pmid">15292309</pub-id></element-citation></ref><ref id="r14"><element-citation publication-type="journal"><person-group person-group-type="editor"><name><surname>Prummel</surname><given-names>MF</given-names></name><name><surname>Wiersinga</surname><given-names>WM</given-names></name></person-group><article-title>Thyroid autoimmunity and miscarriage</article-title><source>Eur J Endocrinol</source><year>2004</year><volume>150</volume><fpage>751</fpage><lpage>755</lpage><pub-id pub-id-type="doi">10.1530/eje.0.1500751</pub-id><?supplied-pmid 15191343?><pub-id pub-id-type="pmid">15191343</pub-id></element-citation></ref><ref id="r15"><element-citation publication-type="journal"><person-group person-group-type="editor"><name><surname>Stagnaro-Green</surname><given-names>A</given-names></name><name><surname>Roman</surname><given-names>SH</given-names></name><name><surname>Cobin</surname><given-names>RH</given-names></name><name><surname>el-Harazy</surname><given-names>E</given-names></name><name><surname>Alvarez-Marfany</surname><given-names>M</given-names></name><name><surname>Davies</surname><given-names>TF</given-names></name></person-group><article-title>Detection of at-risk pregnancy by means of highly sensitive
assays for thyroid autoantibodies</article-title><source>JAMA</source><year>1990</year><volume>264</volume><fpage>1422</fpage><lpage>1425</lpage><pub-id pub-id-type="doi">10.1001/jama.1990.03450110068029</pub-id><?supplied-pmid 2118190?><pub-id pub-id-type="pmid">2118190</pub-id></element-citation></ref><ref id="r16"><element-citation publication-type="journal"><person-group person-group-type="editor"><name><surname>Stagnaro-Green</surname><given-names>A</given-names></name><name><surname>Glinoer</surname><given-names>D</given-names></name></person-group><article-title>Thyroid autoimmunity and the risk of miscarriage</article-title><source>Best Pract Res Clin Endocrinol Metab</source><year>2004</year><volume>18</volume><fpage>167</fpage><lpage>181</lpage><pub-id pub-id-type="doi">10.1016/j.beem.2004.03.007</pub-id><?supplied-pmid 15157834?><pub-id pub-id-type="pmid">15157834</pub-id></element-citation></ref><ref id="r17"><element-citation publication-type="journal"><person-group person-group-type="editor"><name><surname>Thangaratinam</surname><given-names>S</given-names></name><name><surname>Tan</surname><given-names>A</given-names></name><name><surname>Knox</surname><given-names>E</given-names></name><name><surname>Kilby</surname><given-names>MD</given-names></name><name><surname>Franklyn</surname><given-names>J</given-names></name><name><surname>Coomarasamy</surname><given-names>A</given-names></name></person-group><article-title>Association between thyroid autoantibodies and miscarriage and
preterm birth: meta-analysis of evidence</article-title><source>BMJ</source><year>2011</year><volume>342</volume><fpage>d2616</fpage><pub-id pub-id-type="doi">10.1136/bmj.d2616</pub-id><?supplied-pmid 21558126?><pub-id pub-id-type="pmid">21558126</pub-id></element-citation></ref><ref id="r18"><element-citation publication-type="journal"><person-group person-group-type="editor"><name><surname>Unuane</surname><given-names>D</given-names></name><name><surname>Velkeniers</surname><given-names>B</given-names></name><name><surname>Anckaert</surname><given-names>E</given-names></name><name><surname>Schiettecatte</surname><given-names>J</given-names></name><name><surname>Tournaye</surname><given-names>H</given-names></name><name><surname>Haentjens</surname><given-names>P</given-names></name><name><surname>Poppe</surname><given-names>K</given-names></name></person-group><article-title>Thyroglobulin autoantibodies: is there any added value in the
detection of thyroid autoimmunity in women consulting for fertility
treatment?</article-title><source>Thyroid</source><year>2013</year><volume>23</volume><fpage>1022</fpage><lpage>1028</lpage><pub-id pub-id-type="doi">10.1089/thy.2012.0562</pub-id><?supplied-pmid 23405888?><pub-id pub-id-type="pmid">23405888</pub-id></element-citation></ref><ref id="r19"><element-citation publication-type="journal"><person-group person-group-type="editor"><name><surname>Velkeniers</surname><given-names>B</given-names></name><name><surname>Van Meerhaeghe</surname><given-names>A</given-names></name><name><surname>Poppe</surname><given-names>K</given-names></name><name><surname>Unuane</surname><given-names>D</given-names></name><name><surname>Tournaye</surname><given-names>H</given-names></name><name><surname>Haentjens</surname><given-names>P</given-names></name></person-group><article-title>Levothyroxine treatment and pregnancy outcome in women with
subclinical hypothyroidism undergoing assisted reproduction technologies:
systematic review and meta-analysis of RCTs</article-title><source>Hum Reprod Update</source><year>2013</year><volume>19</volume><fpage>251</fpage><lpage>258</lpage><pub-id pub-id-type="doi">10.1093/humupd/dms052</pub-id><?supplied-pmid 23327883?><pub-id pub-id-type="pmid">23327883</pub-id></element-citation></ref><ref id="r20"><element-citation publication-type="journal"><person-group person-group-type="editor"><name><surname>Zhong</surname><given-names>YP</given-names></name><name><surname>Ying</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>HT</given-names></name><name><surname>Zhou</surname><given-names>CQ</given-names></name><name><surname>Xu</surname><given-names>YW</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Shen</surname><given-names>XT</given-names></name><name><surname>Li</surname><given-names>J</given-names></name></person-group><article-title>Relationship between antithyroid antibody and pregnancy outcome
following in vitro fertilization and embryo transfer</article-title><source>Int J Med Sci</source><year>2012</year><volume>9</volume><fpage>121</fpage><lpage>125</lpage><pub-id pub-id-type="doi">10.7150/ijms.3467</pub-id><?supplied-pmid 22253557?><pub-id pub-id-type="pmid">22253557</pub-id></element-citation></ref></ref-list></back></article>